INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543635	ISIN Demat INE0DK501011	Book Value 58.28	NSE Symbol PPLPHARMA	Dividend Yield (%) 0.08	Market Cap (₹ Cr.) 23,195.38	P/E 32.86	EPS 5.31	Face Value 10

Particulars (₹ Cr)	Sep 2025	Jun 2025	Mar 2025	Dec 2024

Gross Sales/Income from operations	1127.26	969.88	1689.8	1248.32
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	1,127.26	969.88	1,689.80	1,248.32
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	1,127.26	969.88	1,689.80	1,248.32
Total Expenses	1,061.44	984.99	1,334.39	1,084.44
Cost of Sales	456.63	426.16	722.97	531.52
Employee Cost	188.52	201.95	198.96	173.55
Depreciation, amortization and depletion expense	61.25	59.44	61.17	55.46
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	355.04	297.44	351.29	323.91
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	65.82	-15.11	355.41	163.88
Other Income	201.97	180.92	39.51	24.70
Profit from ordinary activities before finance costs and exceptional items	267.79	165.81	394.92	188.58
Finance Costs	20.38	23.23	30.56	29.17
Profit from ordinary activities after finance costs but before exceptional items	247.41	142.58	364.36	159.41
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	247.41	142.58	364.36	159.41
Total Tax	51.08	29.44	87.09	40.61
Net profit from Ordinary Activities After Tax	196.33	113.14	277.27	118.80
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	196.33	113.14	277.27	118.80
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	196.33	113.14	277.27	118.80
Other Comprehensive Income	-27.43	-2.71	13.43	-3.53
Total Comprehensive Income	168.90	110.43	290.70	115.27
Equity	1,325.52	1,324.82	1,324.35	1,323.58
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	1.48	0.85	2.09	0.90
EPS before Exceptional/Extraordinary items-Diluted	1.47	0.85	2.09	0.90
EPS after Exceptional/Extraordinary items-Basic	1.48	0.85	2.09	0.90
EPS after Exceptional/Extraordinary items-Diluted	1.47	0.85	2.09	0.90
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00